Filling the need for trusted information on national health issues…

Trending on kff King v. Burwell Medicaid Expansion Tax Season & the ACA

Kaiser Daily Global Health Policy ReportDrug Resistance Search Results « » The Henry J. Kaiser Family Foundation

Drug Resistance

  • your selections
Clear Search

Filter Results

date

Tags

  • results
TB Treatment For Children, MDR-TB Pose Challenges To Stopping Epidemic

International Business Times: World Tuberculosis Day: Why are rates of drug-resistant TB so high in Russia? “…Tuberculosis is the leading infectious killer in Russia. The problem in the region, one of the ‘high priority countries’ highlighted in a recent World Health Organization report, is being fueled by multidrug-resistant tuberculosis (MDR-TB).…

CDC Blog Posts Discuss Issues Surrounding TB, MDR-TB

CDC’s “Our Global Voices”: A Consequence of Conflict: The Spread of Multidrug-Resistant Tuberculosis Nadine Sunderland of the CDC discusses issues surrounding multidrug-resistant tuberculosis (MDR-TB) in Somalia, including preventing, diagnosing, and treating the disease (3/23). CDC’s “Our Global Voices”: An Ounce of Prevention: Why we must strengthen basic TB control to…

U.K. Establishes $289.5M Fund To Combat Antibiotic-Resistant Infections Worldwide

Financial Times: Budget 2015: Fleming Fund to fight drug-resistant infections “[British Chancellor of the Exchequer] George Osborne announced the creation of a £195m [$289.5 million] fund to fight drug-resistant infections worldwide, with contributions from the government, the Wellcome Trust, and other international charities. The Fleming Fund is being set up…

Third Blog Post In Series Examines China’s History Of Artemisinin Drug Development

Council on Foreign Relation’s “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part III In part three of his series on anti-malarial artemisinin drugs, Yanzhong Huang, CFR senior fellow for global health, explores China’s efforts to increase its market share of artemisinin-based combination therapies worldwide. “…To sum up, China has come…

Second Blog Post In Series Examines China’s History Of Artemisinin Drug Development

Council on Foreign Relation’s “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part II In part two of his series on anti-malarial artemisinin drugs, Yanzhong Huang, CFR senior fellow for global health, explores the challenges China faced in marketing its artemisinin-based combination therapies worldwide. “…The 2004-2006 artemisinin bubble nevertheless has not…

IBT Examines Strategies Aimed At Promoting Antibiotic Drug Development

International Business Times: Antibiotic Resistance: Why Aren’t Drug Companies Developing New Medicines To Stop Superbugs? “…[A]s many as 10 million people a year could die from antibiotic-resistant bacteria worldwide by 2050 if new treatments are not discovered, according to a recent report from the Review on Antimicrobial Resistance. … Despite…